Sarah Huber
Medical · Clairton, PANPI 1013566967
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 363 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,581 and has fallen 87.0% since, to $335 in 2025. Among medical clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 363 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$723
- Pfizer$540
- GSK$461
- Amgen$351
- Revance Therapeutics, Inc.$335
- plus $2K from 22 others
What the payments were for
- Food & beverage$6,130100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 96 | $1,347 |
| AbbVie | 50 | $723 |
| Pfizer | 33 | $540 |
| GSK | 27 | $461 |
| Amgen | 22 | $351 |
| Revance Therapeutics, Inc. | 3 | $335 |
| Boehringer Ingelheim | 19 | $324 |
| Amarin Pharma, Inc. | 15 | $302 |
| Daiichi Sankyo Inc. | 15 | $290 |
| Sanofi-aventis U.S. LLC | 17 | $275 |
| Lilly USA, LLC | 9 | $150 |
| E.r. Squibb & Sons, L.L.C. | 8 | $139 |
| Inari Medical, Inc. | 1 | $114 |
| Kowa Pharmaceuticals America, Inc. | 5 | $92 |
| Johnson & Johnson | 5 | $84 |
| Teva Pharmaceuticals USA, Inc. | 6 | $82 |
| AstraZeneca | 5 | $78 |
| Currax Pharmaceuticals LLC | 5 | $71 |
| Merck | 4 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| Dexcom, Inc. | 5 | $69 |
| Edwards Lifesciences | 1 | $38 |
| Genentech USA, Inc. | 3 | $33 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Biogen | 1 | $20 |
| Insightec,inc | 1 | $19 |
| Astellas Pharma US Inc | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,130 in reported general payments places this provider in the 90th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 18 | $1,214 |
| CefuroximeCefuroxime Axetil | 23 | $573 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $174 |
| Prednisone | 42 | $104 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $55 |
| Cyclobenzaprine Hcl | 20 | $45 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $43 |
| Doxycycline Hyclate | 12 | $40 |
| Azithromycin | 11 | $38 |
| Ondansetron Hcl | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other medical in Clairton
- Jacqueline KernaghanSpringfield$426K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.